Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moeko Noguchi-Shinohara

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Internal Medicine (Tokyo, Japan)|October 14, 2024
Anti-amyloid β Antibody Therapies for Alzheimer's Disease: Association between the Target of Amyloid β Aggregates and the Clinical Efficacy of Anti-amyloid β AntibodyMoeko Noguchi-Shinohara, Kenjiro Ono
International Journal of Molecular Sciences|June 28, 2023
The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and TherapeuticsMoeko Noguchi-Shinohara, Kenjiro Ono
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2007
[Epidemiology and surveillance system of prion disease in Japan]Moeko Noguchi-Shinohara, Tsuyoshi Hamaguchi, Masahito Yamada
Internal Medicine (Tokyo, Japan)|February 1, 2026
Therapeutic Potential of Oral ALZ-801 in Patients with Alzheimer's DiseaseDaiki Muramatsu, Moeko Noguchi-Shinohara, Kenjiro Ono
Internal Medicine (Tokyo, Japan)|October 6, 2024
The basis of anti-Aβ antibody therapy: The toxicity of Aβ aggregates and the mechanism of action of anti-Aβ antibodiesKenjiro Ono, Moeko Noguchi-Shinohara, Takahiro Watanabe-Nakayama
Advances in Experimental Medicine and Biology|June 21, 2015
Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral AmyloidosisMasahito Yamada, Kenjiro Ono, Tsuyoshi Hamaguchi, et al.
Nutrients|July 15, 2026
Oral Dysfunction and Cognitive Decline: A Review of Nutritional and Brain Structural Pathways Linking Tooth Loss, Oral Frailty, and Solitary Eating to DementiaHiroyuki Nakamura, Moeko Noguchi-Shinohara, Makoto Murahashi, et al.
Journal of Neurology|March 2, 2011
Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob diseaseMoeko Noguchi-Shinohara, Tsuyoshi Hamaguchi, Ichiro Nozaki, et al.
Experimental Neurology|October 3, 2006
Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitroKenjiro Ono, Moeko Noguchi-Shinohara, Mitsuhiro Yoshita, et al.
Acta Neurologica Scandinavica|November 28, 2020
Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy-related inflammationKenji Sakai, Moeko Noguchi-Shinohara, Tokuhei Ikeda, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Internal Medicine (Tokyo, Japan)|October 14, 2024
Anti-amyloid β Antibody Therapies for Alzheimer's Disease: Association between the Target of Amyloid β Aggregates and the Clinical Efficacy of Anti-amyloid β AntibodyMoeko Noguchi-Shinohara, Kenjiro Ono
International Journal of Molecular Sciences|June 28, 2023
The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and TherapeuticsMoeko Noguchi-Shinohara, Kenjiro Ono
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2007
[Epidemiology and surveillance system of prion disease in Japan]Moeko Noguchi-Shinohara, Tsuyoshi Hamaguchi, Masahito Yamada
Internal Medicine (Tokyo, Japan)|February 1, 2026
Therapeutic Potential of Oral ALZ-801 in Patients with Alzheimer's DiseaseDaiki Muramatsu, Moeko Noguchi-Shinohara, Kenjiro Ono
Internal Medicine (Tokyo, Japan)|October 6, 2024
The basis of anti-Aβ antibody therapy: The toxicity of Aβ aggregates and the mechanism of action of anti-Aβ antibodiesKenjiro Ono, Moeko Noguchi-Shinohara, Takahiro Watanabe-Nakayama
Advances in Experimental Medicine and Biology|June 21, 2015
Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral AmyloidosisMasahito Yamada, Kenjiro Ono, Tsuyoshi Hamaguchi, et al.
Nutrients|July 15, 2026
Oral Dysfunction and Cognitive Decline: A Review of Nutritional and Brain Structural Pathways Linking Tooth Loss, Oral Frailty, and Solitary Eating to DementiaHiroyuki Nakamura, Moeko Noguchi-Shinohara, Makoto Murahashi, et al.
Journal of Neurology|March 2, 2011
Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob diseaseMoeko Noguchi-Shinohara, Tsuyoshi Hamaguchi, Ichiro Nozaki, et al.
Experimental Neurology|October 3, 2006
Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitroKenjiro Ono, Moeko Noguchi-Shinohara, Mitsuhiro Yoshita, et al.
Acta Neurologica Scandinavica|November 28, 2020
Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy-related inflammationKenji Sakai, Moeko Noguchi-Shinohara, Tokuhei Ikeda, et al.
Pageof 8